                         SEQUENCE LISTING

<110>  OXFORD VACMEDIX UK LIMITED
 
<120>  POLYPEPTIDES FOR CANCER TREATMENT

<130>  P000257WO

<150>  2017119.5
<151>  2020-10-28

<160>  52    

<170>  PatentIn version 3.5

<210>  1
<211>  142
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys His 
65                  70                  75                  80  


Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu 
                85                  90                  95      


Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys 
            100                 105                 110         


Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr Ala 
        115                 120                 125             


Lys Lys Val Arg Arg Ala Ile Glu Gln Leu Ala Ala Met Asp 
    130                 135                 140         


<210>  2
<211>  165
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Gly Pro Gly Thr Val Ala 
65                  70                  75                  80  


Tyr Ala Cys Asn Thr Ser Thr Leu Gly Gly Arg Gly Gly Arg Ile Thr 
                85                  90                  95      


Arg Glu Glu His Lys Lys His Ser Ser Gly Cys Ala Phe Leu Ser Val 
            100                 105                 110         


Lys Lys Gln Phe Glu Glu Leu Thr Leu Gly Glu Phe Leu Lys Leu Asp 
        115                 120                 125             


Arg Glu Arg Ala Lys Asn Lys Ile Ala Lys Glu Thr Asn Asn Lys Lys 
    130                 135                 140                 


Lys Glu Phe Glu Glu Thr Ala Lys Lys Val Arg Arg Ala Ile Glu Gln 
145                 150                 155                 160 


Leu Ala Ala Met Asp 
                165 


<210>  3
<211>  137
<212>  PRT
<213>  Homo sapiens

<400>  3

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Met Gln Arg Lys Pro Thr Ile 
65                  70                  75                  80  


Arg Arg Lys Asn Leu Arg Lys Leu Arg Arg Lys Cys Ala Val Pro Ser 
                85                  90                  95      


Ser Ser Trp Leu Pro Trp Ile Glu Ala Ser Gly Arg Ser Cys Leu Val 
            100                 105                 110         


Pro Glu Trp Leu His His Phe Gln Gly Leu Phe Pro Gly Ala Thr Ser 
        115                 120                 125             


Leu Pro Val Gly Pro Leu Ala Met Ser 
    130                 135         


<210>  4
<211>  120
<212>  PRT
<213>  Homo sapiens

<400>  4

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys His 
65                  70                  75                  80  


Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu 
                85                  90                  95      


Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys 
            100                 105                 110         


Ile Glu Arg Ala Leu Leu Ala Glu 
        115                 120 


<210>  5
<211>  117
<212>  PRT
<213>  Homo sapiens

<400>  5

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys His 
65                  70                  75                  80  


Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu 
                85                  90                  95      


Thr Leu Gly Glu Phe Leu Lys Leu Val Arg Glu Thr Leu Pro Pro Pro 
            100                 105                 110         


Arg Ser Phe Ile Arg 
        115         


<210>  6
<211>  78
<212>  PRT
<213>  Homo sapiens

<400>  6

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Met Arg Glu Leu Cys 
65                  70                  75              


<210>  7
<211>  74
<212>  PRT
<213>  Homo sapiens

<400>  7

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Met 
65                  70                  


<210>  8
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  8

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly 
            20                  25                  30  


<210>  9
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  9

Asp His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys 
1               5                   10                  15      


Ala Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His 
            20                  25                  30  


<210>  10
<211>  28
<212>  PRT
<213>  Homo sapiens

<400>  10

Ala Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro 
1               5                   10                  15      


Thr Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe 
            20                  25              


<210>  11
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  11

Pro Thr Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys 
1               5                   10                  15      


Glu Leu Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu 
            20                  25                  


<210>  12
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  12

Phe Lys Glu Leu Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu 
1               5                   10                  15      


His Lys Lys His Ser Ser Gly Cys Ala Phe Leu Ser Val Lys 
            20                  25                  30  


<210>  13
<211>  28
<212>  PRT
<213>  Homo sapiens

<400>  13

Glu His Lys Lys His Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys 
1               5                   10                  15      


Gln Phe Glu Glu Leu Thr Leu Gly Glu Phe Leu Lys 
            20                  25              


<210>  14
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  14

Gln Phe Glu Glu Leu Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu 
1               5                   10                  15      


Arg Ala Lys Asn Lys Ile Ala Lys Glu Thr Asn Asn Lys 
            20                  25                  


<210>  15
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  15

Arg Glu Arg Ala Lys Asn Lys Ile Ala Lys Glu Thr Asn Asn Lys Lys 
1               5                   10                  15      


Lys Glu Phe Glu Glu Thr Ala Glu Lys Val Arg Arg Ala Ile 
            20                  25                  30  


<210>  16
<211>  21
<212>  PRT
<213>  Homo sapiens

<400>  16

Lys Glu Phe Glu Glu Thr Ala Glu Lys Val Arg Arg Ala Ile Glu Gln 
1               5                   10                  15      


Leu Ala Ala Met Asp 
            20      


<210>  17
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A cleavage site for cathepsin S

<400>  17

Leu Arg Met Lys 
1               


<210>  18
<211>  287
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  An artificial peptide with the peptide fragments derived from 
       human survivin isoform 1.

<400>  18

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Leu Arg 
            20                  25                  30          


Met Lys Asp His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu 
        35                  40                  45              


Gly Cys Ala Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His 
    50                  55                  60                  


Leu Arg Met Lys Ala Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe 
65                  70                  75                  80  


Ile His Cys Pro Thr Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe 
                85                  90                  95      


Leu Arg Met Lys Pro Thr Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe 
            100                 105                 110         


Phe Cys Phe Lys Glu Leu Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile 
        115                 120                 125             


Glu Leu Arg Met Lys Phe Lys Glu Leu Glu Gly Trp Glu Pro Asp Asp 
    130                 135                 140                 


Asp Pro Ile Glu Glu His Lys Lys His Ser Ser Gly Cys Ala Phe Leu 
145                 150                 155                 160 


Ser Val Lys Leu Arg Met Lys Glu His Lys Lys His Ser Ser Gly Cys 
                165                 170                 175     


Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu Thr Leu Gly Glu 
            180                 185                 190         


Phe Leu Lys Leu Arg Met Lys Gln Phe Glu Glu Leu Thr Leu Gly Glu 
        195                 200                 205             


Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys Ile Ala Lys Glu 
    210                 215                 220                 


Thr Asn Asn Lys Leu Arg Met Lys Arg Glu Arg Ala Lys Asn Lys Ile 
225                 230                 235                 240 


Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr Ala Glu 
                245                 250                 255     


Lys Val Arg Arg Ala Ile Leu Arg Met Lys Lys Glu Phe Glu Glu Thr 
            260                 265                 270         


Ala Glu Lys Val Arg Arg Ala Ile Glu Gln Leu Ala Ala Met Asp 
        275                 280                 285         


<210>  19
<211>  879
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding an artificial protein derived from 
       human survivin isoform 1.

<400>  19
ggatcccata tgggtgcacc aactcttcct ccagcatggc aacctttcct gaaggatcat       60

cgtatctcta ctttcaagaa ctggccattc ctggaaggtc tgcgtatgaa ggatcaccgt      120

atctctactt tcaagaactg gccattcctt gagggttgtg cttgtactcc tgagcgtatg      180

gctgaggctg gtttcatcca cctgcgtatg aaggcttgca ctcctgaacg tatggctgaa      240

gctggtttca tccactgtcc aactgagaac gagcctgatc tggcacaatg cttcttcctt      300

cgtatgaagc ctactgagaa cgaacctgat ctggctcagt gcttcttctg cttcaaggaa      360

cttgagggtt gggagcctga tgatgatcca atcgagctgc gtatgaagtt caaggagctg      420

gaaggttggg agcctgatga tgatcctatc gaggagcaca agaagcgctc ttctggttgt      480

gctttcctgt ctgtcaaact gcgtatgaag gagcacaaga agcactcttc tggttgtgct      540

ttcctgtctg tcaagaagca gttcgaagaa ctgactctgg gtgagttcct gaagctgcgt      600

atgaagcagt tcgaggagct gactctgggt gagttcctga agctggatcg tgaacgtgct      660

aagaacaaga tcgctaagga gactaacaac aagctgcgta tgaagcgtga gcgtgctaag      720

aacaagatcg ctaaggagac taacaacaag aagaaggagt tcgaggagac tgctgagaag      780

gttcgtcgtg ctatccttcg tatgaagaag gagttcgagg agactgctga gaaggttcgt      840

cgtgctatcg agcagctggc tgccatggac taactcgag                             879


<210>  20
<211>  426
<212>  DNA
<213>  Homo sapiens

<400>  20
atgggcgccc ccaccctgcc ccccgcctgg cagcccttcc tgaaggacca caggatcagc       60

accttcaaga actggccctt cctggagggc tgcgcctgca cccccgagag gatggccgag      120

gccggcttca tccactgccc caccgagaac gagcccgacc tggcccagtg cttcttctgc      180

ttcaaggagc tggagggctg ggagcccgac gacgacccca tcgaggagca caagaagcac      240

agcagcggct gcgccttcct gagcgtgaag aagcagttcg aggagctgac cctgggcgag      300

ttcctgaagc tggacaggga gagggccaag aacaagatcg ccaaggagac caacaacaag      360

aagaaggagt tcgaggagac cgccaagaag gtgaggaggg ccatcgagca gctggccgcc      420

atggac                                                                 426


<210>  21
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 1 of 22 synthetic gene fragments).

<400>  21
ggatcccata tgggtgcacc aactcttcct ccagcatggc aacctttcct gaaggatcat       60


<210>  22
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 2 of 22 synthetic gene fragments).

<400>  22
gaccttccag gaatggccag ttcttgaaag tagagatacg atgatccttc aggaaaggtt       60


<210>  23
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 3 of 22 synthetic gene fragments).

<400>  23
ctggccattc ctggaaggtc tgcgtatgaa ggatcaccgt atctctactt tcaagaactg       60


<210>  24
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 4 of 22 synthetic gene fragments).

<400>  24
catacgctca ggagtacaag cacaaccctc aaggaatggc cagttcttga aagtagagat       60


<210>  25
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 5 of 22 synthetic gene fragments).

<400>  25
cttgtactcc tgagcgtatg gctgaggctg gtttcatcca cctgcgtatg aaggcttgca       60


<210>  26
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 6 of 22 synthetic gene fragments).

<400>  26
ggacagtgga tgaaaccagc ttcagccata cgttcaggag tgcaagcctt catacgcagg       60


<210>  27
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 7 of 22 synthetic gene fragments).

<400>  27
gctggtttca tccactgtcc aactgagaac gagcctgatc tggcacaatg cttcttcctt       60


<210>  28
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present
       invention (number 8 of 22 synthetic gene fragments).

<400>  28
actgagccag atcaggttcg ttctcagtag gcttcatacg aaggaagaag cattgtgcca       60


<210>  29
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present 
       invention (number 9 of 22 synthetic gene fragments).

<400>  29
cgaacctgat ctggctcagt gcttcttctg cttcaaggaa cttgagggtt gggagcctga       60


<210>  30
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding part of a polypeptide of the present
       invention (number 10 of 22 synthetic gene fragments).

<400>  30
cagctccttg aacttcatac gcagctcgat tggatcatca tcaggctccc aaccctcaag       60


<210>  31
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 11 of 22 synthetic gene fragments).

<400>  31
gtatgaagtt caaggagctg gaaggttggg agcctgatga tgatcctatc gaggagcaca       60


<210>  32
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 12 of 22 synthetic gene fragments).

<400>  32
agtttgacag acaggaaagc acaaccagaa gagtgcttct tgtgctcctc gataggatca       60


<210>  33
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 13 of 22 synthetic gene fragments).

<400>  33
gctttcctgt ctgtcaaact gcgtatgaag gagcacaaga agcactcttc tggttgtgct       60


<210>  34
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 14 of 22 synthetic gene fragments).

<400>  34
ccagagtcag ttcttcgaac tgcttcttga cagacaggaa agcacaacca gaagagtgct       60


<210>  35
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 15 of 22 synthetic gene fragments).

<400>  35
gttcgaagaa ctgactctgg gtgagttcct gaagctgcgt atgaagcagt tcgaggagct       60


<210>  36
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 16 of 22 synthetic gene fragments).

<400>  36
agcacgttca cgatccagct tcaggaactc acccagagtc agctcctcga actgcttcat       60


<210>  37
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 17 of 22 synthetic gene fragments).

<400>  37
agctggatcg tgaacgtgct aagaacaaga tcgctaagga gactaacaac aagctgcgta       60


<210>  38
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 18 of 22 synthetic gene fragments).

<400>  38
gtctccttac gatcttgttc ttagcacgct cacgcttcat tacgcagctt gttgttagtc       60


<210>  39
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the 
       invention (number 19 of 22 synthetic gene fragments).

<400>  39
aacaagatcg ctaaggagac taacaacaag aagaaggagt tcgaggagac tgctgagaag       60


<210>  40
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the present 
       invention (number 20 of 22 synthetic gene fragments).

<400>  40
cctcgaactc cttcttcata cgaaggatag cacgacgaac cttctcagca gtctcctcga       60


<210>  41
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the 
       invention(number 21 of 22 synthetic gene fragments).

<400>  41
tatgaagaag gagttcgagg agactgctga gaaggttcgt cgtgctatcg agcagctggc       60


<210>  42
<211>  39
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a part of a polypeptide of the 
       invention (number 22 of 22 synthetic gene fragments).

<400>  42
ctcgagttag tccatggcag ccagctgctc gatagcacg                              39


<210>  43
<211>  98
<212>  PRT
<213>  Human papillomavirus type 16

<400>  43

Met His Gly Asp Thr Pro Thr Leu His Glu Tyr Met Leu Asp Leu Gln 
1               5                   10                  15      


Pro Glu Thr Thr Asp Leu Tyr Cys Tyr Glu Gln Leu Asn Asp Ser Ser 
            20                  25                  30          


Glu Glu Glu Asp Glu Ile Asp Gly Pro Ala Gly Gln Ala Glu Pro Asp 
        35                  40                  45              


Arg Ala His Tyr Asn Ile Val Thr Phe Cys Cys Lys Cys Asp Ser Thr 
    50                  55                  60                  


Leu Arg Leu Cys Val Gln Ser Thr His Val Asp Ile Arg Thr Leu Glu 
65                  70                  75                  80  


Asp Leu Leu Met Gly Thr Leu Gly Ile Val Cys Pro Ile Cys Ser Gln 
                85                  90                  95      


Lys Pro 
        


<210>  44
<211>  105
<212>  PRT
<213>  Human papillomavirus type 18

<400>  44

Met His Gly Pro Lys Ala Thr Leu Gln Asp Ile Val Leu His Leu Glu 
1               5                   10                  15      


Pro Gln Asn Glu Ile Pro Val Asp Leu Leu Cys His Glu Gln Leu Ser 
            20                  25                  30          


Asp Ser Glu Glu Glu Asn Asp Glu Ile Asp Gly Val Asn His Gln His 
        35                  40                  45              


Leu Pro Ala Arg Arg Ala Glu Pro Gln Arg His Thr Met Leu Cys Met 
    50                  55                  60                  


Cys Cys Lys Cys Glu Ala Arg Ile Lys Leu Val Val Glu Ser Ser Ala 
65                  70                  75                  80  


Asp Asp Leu Arg Ala Phe Gln Gln Leu Phe Leu Asn Thr Leu Ser Phe 
                85                  90                  95      


Val Cys Pro Trp Cys Ala Ser Gln Gln 
            100                 105 


<210>  45
<211>  35
<212>  PRT
<213>  Human papillomavirus type 16

<400>  45

Met His Gly Asp Thr Pro Thr Leu His Glu Tyr Met Leu Asp Leu Gln 
1               5                   10                  15      


Pro Glu Thr Thr Asp Leu Tyr Cys Tyr Glu Gln Leu Asn Asp Ser Ser 
            20                  25                  30          


Glu Glu Glu 
        35  


<210>  46
<211>  35
<212>  PRT
<213>  Human papillomavirus type 16

<400>  46

Glu Gln Leu Asn Asp Ser Ser Glu Glu Glu Asp Glu Ile Asp Gly Pro 
1               5                   10                  15      


Ala Gly Gln Ala Glu Pro Asp Arg Ala His Tyr Asn Ile Val Thr Phe 
            20                  25                  30          


Cys Cys Lys 
        35  


<210>  47
<211>  35
<212>  PRT
<213>  Human papillomavirus type 16

<400>  47

His Tyr Asn Ile Val Thr Phe Cys Cys Lys Cys Asp Ser Thr Leu Arg 
1               5                   10                  15      


Leu Cys Val Gln Ser Thr His Val Asp Ile Arg Thr Leu Glu Asp Leu 
            20                  25                  30          


Leu Met Gly 
        35  


<210>  48
<211>  23
<212>  PRT
<213>  Human papillomavirus type 16

<400>  48

Ile Arg Thr Leu Glu Asp Leu Leu Met Gly Thr Leu Gly Ile Val Cys 
1               5                   10                  15      


Pro Ile Cys Ser Gln Lys Pro 
            20              


<210>  49
<211>  140
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A polypeptide comprising peptide fragments derived from HPV16 E7.

<400>  49

Met His Gly Asp Thr Pro Thr Leu His Glu Tyr Met Leu Asp Leu Gln 
1               5                   10                  15      


Pro Glu Thr Thr Asp Leu Tyr Cys Tyr Glu Gln Leu Asn Asp Ser Ser 
            20                  25                  30          


Glu Glu Glu Leu Arg Met Lys Glu Gln Leu Asn Asp Ser Ser Glu Glu 
        35                  40                  45              


Glu Asp Glu Ile Asp Gly Pro Ala Gly Gln Ala Glu Pro Asp Arg Ala 
    50                  55                  60                  


His Tyr Asn Ile Val Thr Phe Cys Cys Lys Leu Arg Met Lys His Tyr 
65                  70                  75                  80  


Asn Ile Val Thr Phe Cys Cys Lys Cys Asp Ser Thr Leu Arg Leu Cys 
                85                  90                  95      


Val Gln Ser Thr His Val Asp Ile Arg Thr Leu Glu Asp Leu Leu Met 
            100                 105                 110         


Gly Leu Arg Met Lys Ile Arg Thr Leu Glu Asp Leu Leu Met Gly Thr 
        115                 120                 125             


Leu Gly Ile Val Cys Pro Ile Cys Ser Gln Lys Pro 
    130                 135                 140 


<210>  50
<211>  423
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  A polynucleotide encoding a polynucleotide according to the 
       present invention comprising sequences derived from HPV16 E7.

<400>  50
atgcatggtg ataccccgac cctgcatgaa tatatgctgg atctgcaacc ggaaaccacc       60

gatctgtatt gttatgagca gctgaatgat agcagcgaag aggaattacg catgaaggaa      120

cagctgaacg attcaagcga agaagaggac gaaattgacg gtccggcagg tcaggcagaa      180

ccggatcgtg cacattacaa cattgttacc ttttgttgca aactgagaat gaaacactac      240

aatatcgtga ccttctgctg taaatgtgat agcaccctgc gtctgtgtgt tcagagcacc      300

catgttgata ttcgtacatt agaggacctg ctgatgggcc tgcggatgaa aattcgtacc      360

ctggaagacc tgttaatggg caccctgggt attgtttgtc cgatttgtag ccagaaaccg      420

taa                                                                    423


<210>  51
<211>  279
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A polypeptide accroding to the present invention comprising 
       sequences derived from Mus musculus survivin.

<400>  51

Met His His His His His His Gly Ala Pro Ala Leu Pro Gln Ile Trp 
1               5                   10                  15      


Gln Leu Tyr Leu Lys Asn Tyr Arg Ile Ala Thr Phe Lys Asn Trp Pro 
            20                  25                  30          


Phe Leu Glu Asp Leu Arg Met Lys Asn Tyr Arg Ile Ala Thr Phe Lys 
        35                  40                  45              


Asn Trp Pro Phe Leu Glu Asp Cys Ala Cys Thr Pro Glu Arg Met Ala 
    50                  55                  60                  


Glu Ala Gly Phe Ile His Leu Arg Met Lys Cys Ala Cys Thr Pro Glu 
65                  70                  75                  80  


Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr Glu Asn Glu Pro 
                85                  90                  95      


Asp Leu Ala Gln Cys Phe Phe Cys Leu Arg Met Lys Cys Pro Thr Glu 
            100                 105                 110         


Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu Glu 
        115                 120                 125             


Gly Trp Glu Pro Asp Asp Asn Pro Ile Glu Leu Arg Met Lys Phe Lys 
    130                 135                 140                 


Glu Leu Glu Gly Trp Glu Pro Asp Asp Asn Pro Ile Glu Glu His Arg 
145                 150                 155                 160 


Lys His Ser Pro Gly Cys Ala Phe Leu Thr Val Lys Leu Arg Met Lys 
                165                 170                 175     


Glu His Arg Lys His Ser Pro Gly Cys Ala Phe Leu Thr Val Lys Lys 
            180                 185                 190         


Gln Met Glu Glu Leu Thr Val Ser Glu Phe Leu Lys Leu Asp Leu Arg 
        195                 200                 205             


Met Lys Lys Gln Met Glu Glu Leu Thr Val Ser Glu Phe Leu Lys Leu 
    210                 215                 220                 


Asp Arg Gln Arg Ala Lys Asn Lys Ile Ala Lys Glu Thr Asn Asn Lys 
225                 230                 235                 240 


Leu Arg Met Lys Arg Gln Arg Ala Lys Asn Lys Ile Ala Lys Glu Thr 
                245                 250                 255     


Asn Asn Lys Gln Lys Glu Phe Glu Glu Thr Ala Lys Thr Thr Arg Gln 
            260                 265                 270         


Ser Ile Glu Gln Leu Ala Ala 
        275                 


<210>  52
<211>  294
<212>  DNA
<213>  Human papillomavirus type 16

<400>  52
atgcacggcg acacccccac cctgcacgag tacatgctgg acctgcagcc cgagaccacc       60

gacctgtact gctacgagca gctgaacgac agcagcgagg aggaggacga gatcgacggc      120

cccgccggcc aggccgagcc cgacagggcc cactacaaca tcgtgacctt ctgctgcaag      180

tgcgacagca ccctgaggct gtgcgtgcag agcacccacg tggacatcag gaccctggag      240

gacctgctga tgggcaccct gggcatcgtg tgccccatct gcagccagaa gccc            294


